Ascendis Pharma A/S Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2022-12-14: Form 6-K; Period of report 2022-12-14; Description 6-K; Document d411598d6k.htm.
- 2022-12-05: Form 6-K; Period of report 2022-12-05; Description 6-K; Document d421889d6k.htm.
- 2022-11-14: Form 6-K; Period of report 2022-11-14; Description 6-K; Document d388895d6k.htm.
- 2022-11-14: Form 6-K; Period of report 2022-11-14; Description 6-K; Document d401012d6k.htm.